"Groundbreaking Research on EHV in Horse Racing Alters Industry Response"

Research funded by the Grayson-Jockey Club Research Foundation has led to the discovery of the antiviral drug valaciclovir as an effective treatment for equine herpesvirus-1 (EHV-1) outbreaks. The drug has shown promising results in treating horses showing early signs of illness, such as fevers and mild lethargy, and can significantly reduce viral shedding and transmission. However, there are concerns about overuse and potential viral resistance. The research has changed the way horse owners and veterinarians manage EHV-1 outbreaks and has provided valuable insights into protecting valuable horses from the devastating consequences of EHV infection.